Table 1 from The MATTERS Trial: Safety and Tolerability of Whole-Body Hyperthermia at 41.50°C in Combination with Chemotherapy in Metastatic Cancer Patients

Patient demographics, clinical status, prior treatments (not chronologically sorted), cohort assignment, and screening outcomes for participants enrolled or screened in the MATTERS study.本数据集包含MATTERS研究中入组或接受筛查的参与者的患者人口统计学特征、临床状态、未按时间顺序排序的既往治疗史、队列分配情况以及筛查结局。